EXELIXIS, INC.
Oncology-focused biotech that discovers, develops, and commercializes cancer therapies.
EXEL | US
Overview
Corporate Details
- ISIN(s):
- US30161Q1040
- LEI:
- Country:
- United States of America
- Address:
- 1851 HARBOR BAY PARKWAY, 94502 ALAMEDA
- Website:
- https://www.exelixis.com/
- Sector:
- Manufacturing
Description
Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes therapies for cancer treatment. The company's primary commercial product is cabozantinib, a small molecule inhibitor marketed for multiple cancer indications, including neuroendocrine tumors and certain types of carcinoma. Leveraging a genomics-based approach, Exelixis advances a diverse pipeline of potential medicines. Its research and development programs encompass in-house small molecule discovery and an expanding portfolio of biotherapeutics, such as antibody-drug conjugates and bispecific antibodies. The company pursues both next-generation approaches to established targets and first-in-class opportunities to address unmet needs in oncology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-12 19:08 | English | 7.1 KB | |||
| 2025-12-05 19:51 |
FORM 4
|
English | 7.4 KB | ||
| 2025-11-26 22:05 | English | 8.3 KB | |||
| 2025-11-25 01:47 |
FORM 4
|
English | 7.9 KB | ||
| 2025-11-25 01:47 |
FORM 4
|
English | 7.4 KB | ||
| 2025-11-21 01:51 |
3
|
English | 11.0 KB | ||
| 2025-11-20 22:02 | English | 7.0 KB | |||
| 2025-11-20 02:11 |
FORM 4
|
English | 7.0 KB | ||
| 2025-11-14 01:12 |
FORM 4
|
English | 7.4 KB | ||
| 2025-11-14 01:12 |
FORM 4
|
English | 8.0 KB | ||
| 2025-11-14 01:12 |
FORM 4
|
English | 7.6 KB | ||
| 2025-11-14 01:12 |
FORM 4
|
English | 8.0 KB | ||
| 2025-11-13 22:11 | English | 7.4 KB | |||
| 2025-11-12 23:41 | English | 6.9 KB | |||
| 2025-11-12 22:16 | English | 7.1 KB |
Automate Your Workflow. Get a real-time feed of all EXELIXIS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EXELIXIS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EXELIXIS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
